Shorter or longer breast radiation after surgery for high-risk cancer
Part of Cancer, Injuries & trauma, Skin clinical trials.
This trial compares two schedules of radiation after breast surgery in people with high-risk, node-positive breast cancer. The goal is to see whether giving radiation in 1 week or 2 weeks works well and is safe after standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older.
- You have invasive breast cancer that has been fully removed microscopically (no cancer left behind in tissue samples).
- You had breast surgery with removal of lymph nodes in the armpit area (axillary clearance/dissection), either breast-conserving surgery or full mastectomy.
- Your cancer is high-risk: stage III, or lymph nodes are positive (especially if you received chemotherapy before surgery).
- You cannot have cancer spread to distant organs or involve certain other lymph node areas (supraclavicular/internal mammary nodes).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter, one-week course of radiation to the standard two-week course after a lumpectomy for early-stage breast cancer. The goal is to see if one week is just as effective and safe, making treatment more convenient.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial compares two different schedules of radiation therapy after breast cancer surgery to see if a shorter course is as effective. It may help reduce the number of hospital visits for patients who have had breast-conserving surgery or a mastectomy.
This study tests giving a shorter course of radiation to the whole breast after chemotherapy for early breast cancer. It aims to make treatment more convenient and may be an option for people who have had breast-conserving surgery.
This trial tests shorter radiation schedules for people with breast cancer that has spread to lymph nodes or is high-risk. It aims to find a shorter course of radiation that is just as effective after surgery.
This trial compares two different schedules of radiation therapy after mastectomy and breast reconstruction. One uses standard daily doses over a longer period, and the other uses higher doses over a shorter period. The goal is to see if the shorter schedule works just as well while possibly saving time and reducing side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.